Trials / Completed
CompletedNCT02423889
Stereotactic Volumetric Radiotherapy in Prostate Cancer
Stereotactic Radiotherapy in Low Risk Prostate Cancer: a Phase II Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single arm, phase II, multicentric study. It evaluates the acute and late toxicity after stereotactic radiotherapy in low risk prostate cancer patients. All participants receive a total dose of 36.25 Gy in 5 fractions, twice a week, 7.25 Gy per fraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-09-01
- First posted
- 2015-04-22
- Last updated
- 2016-05-11
Locations
3 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT02423889. Inclusion in this directory is not an endorsement.